These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. A disorder-related variant (E420K) of a PP2A-regulatory subunit (PPP2R5D) causes constitutively active AKT-mTOR signaling and uncoordinated cell growth. Papke CM; Smolen KA; Swingle MR; Cressey L; Heng RA; Toporsian M; Deng L; Hagen J; Shen Y; Chung WK; Kettenbach AN; Honkanen RE J Biol Chem; 2021; 296():100313. PubMed ID: 33482199 [TBL] [Abstract][Full Text] [Related]
23. Genetic Factors in Antiphospholipid Syndrome: Preliminary Experience with Whole Exome Sequencing. Barinotti A; Radin M; Cecchi I; Foddai SG; Rubini E; Roccatello D; Sciascia S; Menegatti E Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33333988 [TBL] [Abstract][Full Text] [Related]
24. Prenatal Diagnosis of Lei T; Zhen L; Yang X; Pan M; Fu F; Han J; Li L; Li D; Liao C Genes (Basel); 2023 Jan; 14(1):. PubMed ID: 36672867 [No Abstract] [Full Text] [Related]
25. A novel familial autosomal dominant mutation in ARID1B causing neurodevelopmental delays, short stature, and dysmorphic features. Smith JA; Holden KR; Friez MJ; Jones JR; Lyons MJ Am J Med Genet A; 2016 Dec; 170(12):3313-3318. PubMed ID: 27570168 [TBL] [Abstract][Full Text] [Related]
26. Deletion of a Single Lysine Residue at Position 292 of CAMK2A Disrupts Protein Function, Causing Severe Epileptic Encephalopathy and Intellectual Disability. Lintas C; Facchiano A; Azzarà A; Cassano I; Tabolacci C; Galasso C; Gurrieri F Genes (Basel); 2023 Jun; 14(7):. PubMed ID: 37510258 [TBL] [Abstract][Full Text] [Related]
27. Amelioration of a neurodevelopmental disorder by carbamazepine in a case having a gain-of-function GRIA3 variant. Hamanaka K; Miyoshi K; Sun JH; Hamada K; Komatsubara T; Saida K; Tsuchida N; Uchiyama Y; Fujita A; Mizuguchi T; Gerard B; Bayat A; Rinaldi B; Kato M; Tohyama J; Ogata K; Shi YS; Saito K; Miyatake S; Matsumoto N Hum Genet; 2022 Feb; 141(2):283-293. PubMed ID: 35031858 [TBL] [Abstract][Full Text] [Related]
28. TBL1XR1 mutations in Pierpont syndrome are not restricted to the recurrent p.Tyr446Cys mutation. Lemattre C; Thevenon J; Duffourd Y; Nambot S; Haquet E; Vuadelle B; Genevieve D; Sarda P; Bruel AL; Kuentz P; Wells CF; Faivre L; Willems M Am J Med Genet A; 2018 Dec; 176(12):2813-2818. PubMed ID: 30365874 [TBL] [Abstract][Full Text] [Related]
29. Extending the phenotype associated with the CSNK2A1-related Okur-Chung syndrome-A clinical study of 11 individuals. Owen CI; Bowden R; Parker MJ; Patterson J; Patterson J; Price S; Sarkar A; Castle B; Deshpande C; Splitt M; Ghali N; Dean J; Green AJ; Crosby C; ; Tatton-Brown K Am J Med Genet A; 2018 May; 176(5):1108-1114. PubMed ID: 29383814 [TBL] [Abstract][Full Text] [Related]
30. A novel homozygous variant in Al-Deri N; Okur V; Ahimaz P; Milev M; Valivullah Z; Hagen J; Sheng Y; Chung W; Sacher M; Ganapathi M J Med Genet; 2021 Sep; 58(9):592-601. PubMed ID: 32843486 [TBL] [Abstract][Full Text] [Related]
31. Whole exome sequencing identifies the first STRADA point mutation in a patient with polyhydramnios, megalencephaly, and symptomatic epilepsy syndrome (PMSE). Bi W; Glass IA; Muzny DM; Gibbs RA; Eng CM; Yang Y; Sun A Am J Med Genet A; 2016 Aug; 170(8):2181-5. PubMed ID: 27170158 [TBL] [Abstract][Full Text] [Related]
32. Compassionate use of everolimus for refractory epilepsy in a patient with MTOR mosaic mutation. Hadouiri N; Darmency V; Guibaud L; Arzimanoglou A; Sorlin A; Carmignac V; Rivière JB; Huet F; Luu M; Bardou M; Thauvin-Robinet C; Vabres P; Faivre L Eur J Med Genet; 2020 Nov; 63(11):104036. PubMed ID: 32805448 [TBL] [Abstract][Full Text] [Related]
33. New Biomarkers for Atherothrombosis in Antiphospholipid Syndrome: Genomics and Epigenetics Approaches. Lopez-Pedrera C; Barbarroja N; Patiño-Trives AM; Collantes E; Aguirre MA; Perez-Sanchez C Front Immunol; 2019; 10():764. PubMed ID: 31040845 [TBL] [Abstract][Full Text] [Related]
34. De novo mutations in CSNK2A1 are associated with neurodevelopmental abnormalities and dysmorphic features. Okur V; Cho MT; Henderson L; Retterer K; Schneider M; Sattler S; Niyazov D; Azage M; Smith S; Picker J; Lincoln S; Tarnopolsky M; Brady L; Bjornsson HT; Applegate C; Dameron A; Willaert R; Baskin B; Juusola J; Chung WK Hum Genet; 2016 Jul; 135(7):699-705. PubMed ID: 27048600 [TBL] [Abstract][Full Text] [Related]
36. Whole exome sequencing is necessary to clarify ID/DD cases with de novo copy number variants of uncertain significance: Two proof-of-concept examples. Giorgio E; Ciolfi A; Biamino E; Caputo V; Di Gregorio E; Belligni EF; Calcia A; Gaidolfi E; Bruselles A; Mancini C; Cavalieri S; Molinatto C; Cirillo Silengo M; Ferrero GB; Tartaglia M; Brusco A Am J Med Genet A; 2016 Jul; 170(7):1772-9. PubMed ID: 27108886 [TBL] [Abstract][Full Text] [Related]
37. De novo heterozygous missense and loss-of-function variants in CDC42BPB are associated with a neurodevelopmental phenotype. Chilton I; Okur V; Vitiello G; Selicorni A; Mariani M; Goldenberg A; Husson T; Campion D; Lichtenbelt KD; van Gassen K; Steinraths M; Rice J; Roeder ER; Littlejohn RO; Srour M; Sebire G; Accogli A; Héron D; Heide S; Nava C; Depienne C; Larson A; Niyazov D; Azage M; Hoganson G; Burton J; Rush ET; Jenkins JL; Saunders CJ; Thiffault I; Alaimo JT; Fleischer J; Groepper D; Gripp KW; Chung WK Am J Med Genet A; 2020 May; 182(5):962-973. PubMed ID: 32031333 [TBL] [Abstract][Full Text] [Related]
38. Clinical and molecular delineation of PUS3-associated neurodevelopmental disorders. Nøstvik M; Kateta SM; Schönewolf-Greulich B; Afenjar A; Barth M; Boschann F; Doummar D; Haack TB; Keren B; Livshits LA; Mei D; Park J; Pisano T; Prouteau C; Umair M; Waqas A; Ziegler A; Guerrini R; Møller RS; Tümer Z Clin Genet; 2021 Nov; 100(5):628-633. PubMed ID: 34415064 [TBL] [Abstract][Full Text] [Related]
39. A null variant in PUS3 confirms its involvement in intellectual disability and further delineates the associated neurodevelopmental disease. Abdelrahman HA; Al-Shamsi AM; Ali BR; Al-Gazali L Clin Genet; 2018 Dec; 94(6):586-587. PubMed ID: 30308082 [No Abstract] [Full Text] [Related]
40. Recessive Inactivating Mutations in TBCK, Encoding a Rab GTPase-Activating Protein, Cause Severe Infantile Syndromic Encephalopathy. Chong JX; Caputo V; Phelps IG; Stella L; Worgan L; Dempsey JC; Nguyen A; Leuzzi V; Webster R; Pizzuti A; Marvin CT; Ishak GE; Ardern-Holmes S; Richmond Z; ; Bamshad MJ; Ortiz-Gonzalez XR; Tartaglia M; Chopra M; Doherty D Am J Hum Genet; 2016 Apr; 98(4):772-81. PubMed ID: 27040692 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]